PCT/US2012/046623
MAP4K3 AS A BIOMARKER AND THERAPETIC TARGET FOR AUTOIMMUNE DISEASE, CANCER, INFLAMMATION AND IL-17- ASSOCIATED DISEASE
Details for PCT/US2012/046623
TAN, Tse-Hua
CHUANG, Huai-Chia
Dates
Deadlines
Abstract
Info
PCT Patent application PCT/US2012/046623 was filed on July 13, 2012 by NATIONAL HEALTH RESEARCH INSTITUTES; TAN, Tse-Hua; CHUANG, Huai-Chia. The title of this PCT Patent Application is "MAP4K3 AS A BIOMARKER AND THERAPETIC TARGET FOR AUTOIMMUNE DISEASE, CANCER, INFLAMMATION AND IL-17- ASSOCIATED DISEASE" and the patent specification was published as WO/2013/010061 on January 17, 2013.
The earliest priority date for the patent application is July 14, 2011 and therefore the 30 month national phase deadline for PCT/US/2012/046623 is January 14, 2014 and the 31 month national phase deadline for PCT/US/2012/046623 is February 14, 2014
Legal
The information provided herein is not legal or other professional advice. The information herein may be provided from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein.